Get started
Ironwood Pharmaceuticals, Inc.Ironwood Pharmaceuticals, Inc.Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

IRWD chart


Full chart

IRWD upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪116.86 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
66.8704
Basic EPS (TTM)
0.0110 USD
Net income (FY)
‪880.00 K‬ USD
Revenue (FY)
‪351.41 M‬ USD
Shares float
‪156.66 M‬
Beta (1Y)
0.21

Employees


Employees (FY)
253
Change (1Y)
−14 −5.24%
Revenue / Employee (1Y)
‪1.39 M‬ USD
Net income / Employee (1Y)
‪3.48 K‬ USD

About Ironwood Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas A. McCourt
Website
ironwoodpharma.com
Headquarters
Boston
Founded
1998
FIGI
BBG000GBZ3J2
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

IRWD news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

IRWD highest yielding bonds


IRWD5031499
Ironwood Pharmaceuticals, Inc. 1.5% 15-JUN-2026
Yield to maturity
14.32%
Maturity date
Jun 15, 2026

See all IRWD bonds 


Check out other big names from the same industry as IRWD.

Frequently Asked Questions


The current price of IRWD is 0.8112 USD — it has increased by 4.53% in the past 24 hours. Watch Ironwood Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ironwood Pharmaceuticals, Inc. stocks are traded under the ticker IRWD.
IRWD stock has fallen by −30.74% compared to the previous week, the month change is a −49.67% fall, over the last year Ironwood Pharmaceuticals, Inc. has showed a −89.53% decrease.
We've gathered analysts' opinions on Ironwood Pharmaceuticals, Inc. future price: according to them, IRWD price has a max estimate of 13.00 USD and a min estimate of 0.70 USD. Watch IRWD chart and read a more detailed Ironwood Pharmaceuticals, Inc. stock forecast: see what analysts think of Ironwood Pharmaceuticals, Inc. and suggest that you do with its stocks.
IRWD reached its all-time high on Jul 13, 2018 with the price of 17.7554 USD, and its all-time low was 0.9050 USD and was reached on Apr 9, 2025. View more price dynamics on IRWD chart.
See other stocks reaching their highest and lowest prices.
IRWD stock is 26.66% volatile and has beta coefficient of 0.21. Track Ironwood Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Ironwood Pharmaceuticals, Inc. there?
Today Ironwood Pharmaceuticals, Inc. has the market capitalization of ‪116.86 M‬, it has decreased by −24.26% over the last week.
Yes, you can track Ironwood Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Ironwood Pharmaceuticals, Inc. is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
IRWD earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0.085 USD resulting in a −76.35% surprise. The estimated earnings for the next quarter are −0.041 USD per share. See more details about Ironwood Pharmaceuticals, Inc. earnings.
Ironwood Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪90.55 M‬ USD, despite the estimated figure of ‪93.77 M‬ USD. In the next quarter, revenue is expected to reach ‪64.06 M‬ USD.
IRWD net income for the last quarter is ‪3.19 M‬ USD, while the quarter before that showed ‪3.65 M‬ USD of net income which accounts for −12.53% change. Track more Ironwood Pharmaceuticals, Inc. financial stats to get the full picture.
No, IRWD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 16, 2025, the company has 253 employees. See our rating of the largest employees — is Ironwood Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ironwood Pharmaceuticals, Inc. EBITDA is ‪107.95 M‬ USD, and current EBITDA margin is 27.81%. See more stats in Ironwood Pharmaceuticals, Inc. financial statements.
Like other stocks, IRWD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ironwood Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ironwood Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ironwood Pharmaceuticals, Inc. stock shows the sell signal. See more of Ironwood Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.